# SUBLIVAC FIX Mite Mixture Dose Tolerability Study

> **NCT02345278** · PHASE1,PHASE2 · COMPLETED · sponsor: **HAL Allergy** · enrollment: 81 (actual)

## Conditions studied

- House Dust Mite Allergy

## Interventions

- **DRUG:** SUBLIVAC FIX Mite mixture
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02345278
- **Lead sponsor:** HAL Allergy
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05
- **Primary completion:** 2015-11
- **Final completion:** 2015-11
- **Target enrollment:** 81 (ACTUAL)
- **Last updated:** 2015-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02345278

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02345278, "SUBLIVAC FIX Mite Mixture Dose Tolerability Study". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02345278. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*